Gingko Bioworks, Synplogen to advance gene therapy services in Japan (DNA)

Retrieved on: 2023-12-06 22:35:10

Tags for this article:

Click the tags to see associated articles and topics

Gingko Bioworks, Synplogen to advance gene therapy services in Japan (DNA). View article details on hiswai:

Excerpt

Gingko Bioworks (NYSE:DNA) said it has entered into a non-binding memorandum of understanding with Japanese synthetic biology startup Synplogen to ...

Article found on: seekingalpha.com

View Original Article